Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab
<p>Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysiology of macular edema involves both the presence of inflammation and angiogenic stimulant</p><p>regarding vascular endothelial growth factor (VEGF) [1]. Intravitreal injections o...
-д хадгалсан:
Үндсэн зохиолчид: | Fang-Ting Chen (Зохиогч), Jia-Kang Wang (Зохиогч) |
---|---|
Формат: | Ном |
Хэвлэсэн: |
Journal of Clinical Research and Ophthalmology - Peertechz Publications,
2015-02-15.
|
Нөхцлүүд: | |
Онлайн хандалт: | Connect to this object online. |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
-н: Messenger WB, зэрэг
Хэвлэсэн: (2013) -
Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
-н: Stéphanie Baillif, зэрэг
Хэвлэсэн: (2022) -
Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
-н: A. E. Cheberda, зэрэг
Хэвлэсэн: (2018) -
Efficacy and Safety of Fluocinolone Acetonide Implant in Diabetic Macular Edema: Practical Guidelines from Reference Center
-н: Lucas Sejournet, зэрэг
Хэвлэсэн: (2024) -
Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review
-н: Laurent Kodjikian, зэрэг
Хэвлэсэн: (2021)